8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Caregiver Burden with Duchenne and Becker Muscular Dystrophy in Japan: A Clinical Observation Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Skeletal muscle weakness and cardiomyopathy can be seen in carriers of dystrophinopathy. Therefore, the health management of caregivers of Duchenne/Becker muscular dystrophy (DMD/BMD) patients who are themselves carriers is an important issue. However, few studies have focused on caregivers who have dystrophin mutations.

          Methods

          In this cross-sectional study conducted at five hospitals, the daily living, situation medical treatment status, genetic testing, physical assessment, care burden, and quality of life of caregivers of DMD/BMD patients were surveyed.

          Results

          The subjects were 36 main caregivers (mean age 55.7±8.4 years old), of whom 52.8% were diagnosed as carriers, 8.3% were noncarriers, and 38.9% were not confirmed. In addition, half of the caregivers were not examined regularly at medical institutions. Of all caregivers, 54.3% had muscle or cardiac symptoms, and 75% had elevated serum creatine kinase levels. The mean Zarit Caregiver Burden Interview (ZBI) total score of current caregivers was 20.9±13.1. The frequency of a ZBI total score ≥25 was significantly higher in caregivers diagnosed as carriers than in caregivers unexamined as carriers (p=0.04). The health-related quality of life score (Short Form 36; SF-36) in caregivers was slightly lower than the Japanese standard scores in the sections of physical functioning, role limitations-physical, bodily pain, and social functioning.

          Conclusion

          Some caregivers of DMD/BMD patients can themselves have muscular or cardiac symptoms and a heavy care burden. It is therefore necessary for carrier caregivers, especially women, to undergo regular health checkups and receive appropriate health management.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Relatives of the Impaired Elderly: Correlates of Feelings of Burden

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

            The protein product of the human Duchenne muscular dystrophy locus (DMD) and its mouse homolog (mDMD) have been identified by using polyclonal antibodies directed against fusion proteins containing two distinct regions of the mDMD cDNA. The DMD protein is shown to be approximately 400 kd and to represent approximately 0.002% of total striated muscle protein. This protein is also detected in smooth muscle (stomach). Muscle tissue isolated from both DMD-affected boys and mdx mice contained no detectable DMD protein, suggesting that these genetic disorders are homologous. Since mdx mice present no obvious clinical abnormalities, the identification of the mdx mouse as an animal model for DMD has important implications with regard to the etiology of the lethal DMD phenotype. We have named the protein dystrophin because of its identification via the isolation of the Duchenne muscular dystrophy locus.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey.

              Cross-sectional data from a representative sample of the general population in Japan were analyzed to test the validity of Japanese SF-36 Health Survey scales as measures of physical and mental health. Results from psychometric and clinical tests of validity were compared. Principal components analyses were used to test for the hypothesized physical and mental dimensions of health and the pattern of scale correlations with those components. To test the clinical validity of SF-36 scale scores, self-reports of chronic medical conditions and the Zung Self-Rating Depression Scale were used to create mutually exclusive groups differing in the severity of physical and mental conditions. The pattern of correlations between the SF-36 scales and the two empirically derived components generally confirmed hypotheses for most scales. Results of psychometric and clinical tests of validity were in agreement for the Physical Functioning, Role-Physical, Vitality, Social Functioning, and Mental Health scales. Relatively less agreement between psychometric and clinical tests of validity was observed for the Bodily Pain, General Health, and Role-Emotional scales, and the physical and mental health factor content of those scales was not consistent with hypotheses. In clinical tests of validity, the General Health, Bodily Pain, and Physical Functioning scales were the most valid scales in discriminating between groups with and without a severe physical condition. Scales that correlated highest with mental health in the components analysis (Mental Health and Vitality) also were most valid in discriminating between groups with and without depression. The results of this study provide preliminary interpretation guidelines for all SF-36 scales, although caution is recommended in the interpretation of the Role-Emotional, Bodily Pain, and General Health scales pending further studies in Japan.
                Bookmark

                Author and article information

                Journal
                Intern Med
                Intern Med
                Internal Medicine
                The Japanese Society of Internal Medicine
                0918-2918
                1349-7235
                21 June 2023
                1 February 2024
                : 63
                : 3
                : 365-372
                Affiliations
                [1 ]Department of Neurology, National Hospital Organization Kumamoto Saishun Medical Center, Japan
                [2 ]Department of Neurology, National Hospital Organization Akita National Hospital, Japan
                [3 ]Clinical Research Management Center, Nagoya City University Hospital, Japan
                [4 ]Department of Neurology, National Hospital Organization Matsumoto Medical Center, Japan
                [5 ]Department of Neurology, National Hospital Organization Osaka Toneyama Medical Center, Japan
                Author notes

                Correspondence to Dr. Masatoshi Ishizaki, ishizaki.masatoshi.hs@ 123456mail.hosp.go.jp

                Article
                10.2169/internalmedicine.9372-22
                10901721
                37344421
                7430490d-566b-48fe-b4a6-605128ab495b
                Copyright © 2024 by The Japanese Society of Internal Medicine

                The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit ( https://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 13 January 2022
                : 14 May 2023
                Categories
                Original Article

                duchenne/becker muscular dystrophy,carrier,caregiver,health assessment

                Comments

                Comment on this article